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(57) ABSTRACT 
Papillary muscle position control devices (900) systems and 
methods are provided. According to an exemplary embodi-
ment, a papillary muscle position control device generally 
comprises a first anchor (905), a second anchor (920), and a 
support structure (915). The first anchor can be configured to 
fixedly connect to an in situ valve of a heart ventricle. The 
second anchor can be configured to fixedly connect to a 
muscle wall of the valve. The support structure can be con-
figured to have an adjustable length and be coupled to the first 
anchor and second anchor such that adjusting the length of the 
support structure varies a distance between the first anchor 
and the second anchor. Other embodiments are also claimed 
and described. 
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PAPILLARY MUSCLE POSITION CONTROL 
DEVICES, SYSTEMS, AND METHODS 
BENEFIT & PRIORITY CLAIMS 
This application is a 35 U.S.C. §371 US National Stage of 
International Application No. PCT /US2006/062185 filed 15 
Dec. 2006, which claims the benefit of U.S. Ser. No. 601750, 
561, filed 15 Dec. 2005. 
TECHNICAL FIELD 
The various embodiments of the present invention relate 
generally to heart valve repair devices and methods, and more 
particularly, to devices and methods capable of positioning 
and controlling papillary muscles of an atrioventricularvalve. 
BACKGROUND 
Cardiovascular disease accounts for nearly fifty percent of 
deaths in both the developed world and in developing coun-
tries. The risk of dying from heart disease is greater than the 
risk from AIDS and all forms of cancer combined. Cardio-
vascular diseases cause approximately 12 million deaths in 
the world each year. It is the leading cause of death in the US, 
killing approximately 950,000 people each year. It also 
accounts for a significant amount of disability and diminished 
quality oflife. Indeed, approximately 60 million people in the 
US alone have some form of heart disease. A great need, 
therefore, exists for the advancement of devices, methods, 
systems, and procedures to cure, treat, and correct a wide 
variety of forms of heart disease. 
Normal heart function primarily relies upon the proper 
function of each of the four valves of the heart, which allow 
blood to pass through the four chambers of the heart. These 
four valves have cusps or leaflets, comprised of fibrous tissue, 
which attach to the walls of the heart. The four chambers of 
the heart include the right atrium and left atrium, the upper 
chambers, and the right ventricle and left ventricle, the lower 
chambers. The four valves, controlling blood flow in and 
between the chambers, include the tricuspid, mitral, pulmo-
nary, and aortic valves. Heart valves are complex structures 
that consist of moveable leaflets that open and close the valve. 
For example, the mitral valve has two leaflets and the tricus-
pid valve has three leaflets. The aortic and pulmonary valves 
have three leaflets that are more aptly termed "cusps," as they 
have a half moon shape. 
The cardiac cycle involves the pumping and distribution of 
both oxygenated and deoxygenated blood within the four 
chambers. Oxygenated blood, enriched by the lungs, reenters 
the heart into the left atrium or left upper chamber. The mitral 
valve, a one way inflow valve, then directs the oxygenated 
blood into the left ventricle. The contraction of the left ven-
tricle pumps the oxygenated blood through the aortic valve, 
into the aorta, and into the blood stream. When the left ven-
tricle contracts the mitral valve closes such that the oxygen-
ated blood passes into the aorta. Deoxygenated blood returns 
from the body via the right atrium. This deoxygenated blood 
flows through the tricuspid valve into the right ventricle. 
When the right ventricle contracts, the tricuspid valve closes 
and the deoxygenated blood is pumped through the pulmo-
nary valve. Deoxygenated blood is directed to the pulmonary 
vascular bed for oxygenation, and the cardiac cycle repeats 
itself. 
2 
in almost 20% of men and women who have an echocardio-
gram. Mitra! valve regurgitation, or mitral regurgitation, is a 
condition in which the mitral valve doesn't close tightly. It 
results from the failure of the mitral valve leaflets to com-
pletely close when the left ventricle contracts, resulting in the 
flow of blood back into the left atrium due to an overworked 
left atrium. This allows blood to flow backward in the heart 
which in turn can lead to serious heart conditions such as 
congestive heart failure and serious heart rhythm irregulari-
ties (arrhythmias). Mitra! valve regurgitation is also a pro-
lO gressive condition that, if not corrected, can be fatal. 
Also, approximately 40% of patients having some form of 
surgery in an attempt to correct mitral valve regurgitation end 
up with either 1+ or 2+ regurgitation measurements. While 
this may result in improved regurgitation characteristics, the 
15 future for these patients can involve additional surgery as 
their improved regurgitation characteristics will typically 
degrade over time as 1 + or 2+ regurgitation can negatively 
affect heart valve functionality. 
The function of an atrioventricular valve, like the mitral 
20 valve, involves the complex interaction of numerous compo-
nents, including the leaflets, chordae tendineae, and papillary 
muscles. If one of the components or functions of the com-
plicated interaction fails, then mitral valve regurgitation can 
result. For example, excess leaflet tissue, inadequate leaflet 
25 tissue, or restricted motion of the leaflets can lead to mitral 
regurgitation. 
Techniques currently exist to assist in correcting the shape 
of a mitral valve to control the geometries of mitral valve 
shape. For example, one conventional technique includes sur-
30 gically reshaping the ventrical with extensive surgical 
manipulation. Another conventional technique involves 
reshaping the geometry of the annulus of the ventrical with a 
ring or other annuloplasty device. Another conventional 
device is the Coapsys Device manufactured by Myocor, Inc. 
35 (Maple Grove, Minn. USA) and described in U.S. Pat. Nos. 
6,332,893 and 7,077,862. 
These conventional techniques, while serving their respec-
tive purposes, do posses drawbacks. For example, certain of 
these conventional techniques, can at times, require extensive 
40 surgery which can increase possible associated risks to 
patients. Also, these techniques do not utilize an atrioven-
tricular valve's papillary muscles to assist in reshaping valve 
geometry by apically adjusting a papillary muscle to control 
valve regurgitation. Further, these conventional devices do 
45 not enable fine tuning adjustments to be made on a beating 
heart to control, reduce, and eliminate blood regurgitation in 
atrioventricular valves. 
Accordingly, there is a need for devices and methods to 
control the position of papillary muscles relative to an annu-
50 !us of an atrioventricular valve. In addition, there is a need for 
devices and methods to reposition a papillary muscle using a 
positioning device to assist in controlling, reducing, and 
eliminating blood regurgitation. Still yet, there is a need for 
devices and processes enabling apical adjustability of posi-
55 tions between papillary muscles and an annulus of an associ-
ated atrioventricular valve. There is still yet a further need for 
devices and methods enabling fine tuning adjustments to be 
made on a beating heart to control, reduce, and eliminate 
blood regurgitation in atrioventricular valves. It is to the pro-
60 vision of such papillary muscle positioning devices, systems, 
processes, and methods that the various embodiments of the 
present invention are directed. 
BRIEF SUMMARY 
Mitra! valve regurgitation is one the most prevalent heart 65 
disease conditions, which has many levels of severity. After Embodiments of the present invention provide devices and 
methods capable of controlling positioning of papillary 55 years of age, some degree of mitral regurgitation is found 
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muscles and an annulus of an atrioventricular valve. Accord-
ing to some embodiments, the present invention comprises 
methods, implants, and tools enabling control of a relative 
position between papillary muscles of an atrioventricular 
valve and an associated annulus to aid in reshaping the geom-
etry of the annulus to control, reduce, and eliminate blood 
flow regurgitation. Some embodiments can be used with an 
annuloplasty device, and other embodiments may not use an 
annuloplasty device. 
4 
Generally described, a papillary muscle positioning device 
can comprise a first anchor, a second anchor, and a support 
structure. The term anchor is at times used synonymously 
with pad herein. The first anchor can be configured to fixedly 
connect to an in situ valve of a heart ventricle, and the second 
anchor can be configured to fixedly connect to a muscle wall 15 
of the valve. The support structure can be configured to have 
attached to the tip of the papillary muscle. Also, one end of the 
device can be attached proximate the base of the papillary 
muscle one end of the device can secured to at least a portion 
of the exterior of the papillary muscle. The device can be 
provided with corresponding internal locking members 
adapted to adjust the length of the device according to some 
methods. And according to some methods, the device can 
comprise multiple support structures each connected to a 
separate papillary muscle. The multiple support structures 
10 
can have adjustable lengths to alter the distance between the 
valve muscle and the valve annulus. 
According to another embodiment of the present invention, 
a papillary muscle position system can comprise a first sup-
port structure and a first adjustment mechanism. The first 
support structure can be coupled to a first papillary muscle 
and the first adjustment mechanism can be coupled to the first 
support structure to adjust the length of the first support 
structure to position the first papillary muscle. A system can 
an adjustable length and coupled to the first anchor and sec-
ond anchor. In this configuration, the length of support struc-
ture can be adjusted to vary a distance between the first anchor 
and the second anchor, which in tum can vary the distance 20 
between the in situ valve and the muscle wall. 
also comprise a second support structure coupled to a second 
papillary muscle, and a second adjustment mechanism 
A device embodiment of the present invention can also 
include additional features. For example, the first anchor can 
be an annuloplasty ring secured to an annulus of the valve. 
The second anchor can penetrate the muscle wall at a papil-
lary muscle to enable the adjustable length support structure 
to vary a distance between the papillary muscle and the first 
anchor. Still yet, a device can further comprise one of an 
internal restraint disposed within the valve or an external 
restraint disposed about an exterior of the valve. These 
restraint can alter a lateral position of the papillary muscle. 
Still yet other features are also contemplated for devices 
according to the present invention. For example, the support 
structure can have a generally circular or generally square 
cross-sectional shape. The first anchor and the second anchor 
can comprise a lock to engage the support structure. The 
support structure can comprise an internal locking region to 
enable the length of the support structure to be locked of fixed. 
The first anchor can be an annulus anchor comprising flexible 
arms that extend at least partially around a perimeter of the 
annulus. The first anchor can comprise a connection mecha-
nism adapted to connect to an annuloplasty device. And the 
support structure can comprise interior corresponding 
threaded regions enabling the length of the support structure 
to be adjusted. 
Embodiments of the present invention also include meth-
ods to position a papillary muscle. Broadly described, a 
method to control a distance between a valve muscle and a 
valve annulus in a human heart can comprise providing a 
device configured to be positioned between a valve muscle 
and a valve annulus; disposing the device between the valve 
muscle and the valve annulus; and adjusting a length of the 
device to alter the distance between the valve muscle and the 
valve annulus. A positioning method can also comprise 
attaching the device to at least one of an annulus ring or a 
papillary muscle. Another feature of a positioning method can 
include rotating one end of the device relative to another end 
of the device to adjust the length of the device. 
Other method embodiments of the present invention can 
include additional steps. For example, a method can comprise 
flexing one end of the device relative to another end of the 
device to adjust the length of the device. Also, a method can 
comprise attaching the device to at least one exterior area 
proximate a papillary muscle of the valve muscle, or provid-
ing a tension member to tension the valve muscle to change 
the shape of the valve muscle. The valve muscle can be a 
papillary muscle having a tip, and one end of the device can be 
coupled to the second support structure to adjust the length of 
the second support structure to position the second papillary 
muscle. A system can also include an annuloplasty device 
25 coupled to an annulus of an atrioventricularvalve and coupled 
to the first and second adjustment mechanisms. In this con-
figuration, the first and second adjustment mechanisms can be 
positioned proximate the annulus. Also, a system can com-
prise an anchor disposed proximate the first papillary muscle. 
30 The anchor can receive the first support structure so that the 
first support structure is coupled to the first papillary muscle. 
Other features are also contemplated according to addi-
tional system embodiments. For example, an anchor can be 
attached to one of the exterior of the first papillary muscle or 
35 beneath the first papillary muscle on an exterior surface of an 
associated valve wall. Also, the support structure can be a 
suture that is looped about the first papillary muscle. In 
another configuration, the first adjustment mechanism can 
comprise threaded components that interact with each other 
40 to adjust a length of the first support structure. One of the 
treaded components can be coupled to the first support struc-
ture. Alternatively, the first adjustment mechanism can com-
prise a pin to lockably engage the first support structure to fix 
the length of the first support structure. The first support 
45 structure can be a semi-rigid elongated rod that flexes in a 
substantially unidirectional manner. And the first support 
structure can house an internal security wire to secure the first 
support structure according to some embodiments. 
Still yet, other embodiments of the present invention 
50 include additional method embodiments. According to other 
method embodiments, a method to position a papillary 
muscle can comprise coupling a first end of a support struc-
ture to a papillary muscle; coupling a second end of the 
support structure proximate an annulus of a valve; and adjust-
55 ing the position of the papillary muscle in a substantially 
apical direction with an adjustment device so that the papil-
lary muscle is positioned closer to the annulus. A method can 
also comprise providing an anchor proximate the papillary 
muscle, the anchor to receive the first end of the support 
60 structure. A method can also include coupling the adjustment 
device to an annuloplasty device coupled to the annulus. 
Another method embodiment can comprise positioning the 
adjustment device proximate at least one of the papillary 
muscle or the annulus. Compressing a papillary muscle to 
65 alter at least one of the shape, position, or length of the 
papillary muscle can also be included in a method embodi-
ment. 
US 9,125,742 B2 
5 
In yet another embodiment of the present invention, a 
papillary muscle positioning device generally comprises a 
support structure and an adjustment mechanism. The support 
structure can be disposed between a papillary muscle and an 
annulus. The adjustment device can lockably engage the sup-
port structure to alter the length of the support structure and to 
fix the length of the support structure at an altered length. The 
adjustment device can be attached proximate to at least one of 
the annulus, an annuloplasty device coupled to the annulus, 
the papillary muscle, or disposed partially within the papil- 10 
lary muscle. Also, at least one of the support structure or the 
adjustment device can comprise threaded components. In this 
configuration, the threaded components can interact with 
each other in response to an applied mechanical force such 15 
that one of the threaded components can move relative to and 
lockably engage the other threaded component. 
Accordingly, it is an aspect of some embodiments of the 
present invention to provide a cardiovascular implant to con-
trol the geometry, size, and area of an annulus of an atrioven- 20 
tricular valve and the relative position between papillary 
muscles and an annulus of an atrioventricular valve. 
Another aspect of some embodiments of the present inven-
tion is to control the relative position between papillary 
muscles and an annulus of an atrioventricular valve. 
Another aspect of some embodiments of the present inven-
tion is to provide a cardiovascular implant to control the 
apical position between papillary muscles and an annulus of 
an atrioventricular valve 
25 
Other aspects according to some embodiments of the 30 
present invention include providing a cardiovascular implant 
to control the chordal force distribution of an atrioventricular 
valve or to reduce the length of a papillary muscle. 
Still yet other aspects according to some embodiments of 35 
the present invention include providing a cardiovascular 
implant which may be delivered percutaneously or thoroco-
scopically to control a relative position between papillary 
muscles and an annulus of an atrioventricular valve. 
Still yet another aspect according to some embodiments of 40 
the present invention includes providing a cardiovascular 
implant that can be fine tuned and adjusted on a beating heart 
to control, reduce, and eliminate blood flow regurgitation. 
Other aspects and features of embodiments of the present 
invention will become apparent to those of ordinary skill in 45 
the art, upon reviewing the following description of specific, 
exemplary embodiments of the present invention in conjunc-
tion with the accompanying figures. 
6 
FIG. 6 illustrates a device to control a position of a papil-
lary muscle including a support that does not penetrate a 
papillary muscle according to some embodiments of the 
present invention. 
FIG. 7 illustrates a device to control a position of a papil-
lary muscle including support structures having variable 
lengths according to some embodiments of the present inven-
tion. 
FIG. 8 illustrates a device to control a position of a papil-
lary muscle including internally threaded support structures 
according to some embodiments of the present invention. 
FIG. 9 illustrates yet another device to control a position of 
a papillary muscle according to some embodiments of the 
present invention. 
FIG. 10 illustrates a device to control a position of a pap-
illary muscle including a compression force system accord-
ing to some embodiments of the present invention. 
FIG. 11 illustrates a device to control a position of a pap-
illary muscle including another compression force system 
according to some embodiments of the present invention. 
FIG. 12 illustrates a logical flow diagram depicting a 
method embodiment of the present invention capable of 
reforming an atrioventricular valve by controlling position of 
an associated papillary muscle. 
DETAILED DESCRIPTION OF PREFERRED & 
ALTERNATIVE EMBODIMENTS 
Referring now to the figures, wherein like reference numer-
als represent like parts throughout the several views, exem-
plary embodiments of the present invention will be described 
in detail. Throughout this description, various components 
may be identified having specific values or parameters, how-
ever, these items are provided as exemplary embodiments. 
For example, it should be understood that while some 
embodiments are discussed with specific reference to mitral 
valves, embodiments of the present invention can be utilized 
in conjunction with any atrioventricular valve. Thus, the 
exemplary embodiments do not limit the various aspects and 
concepts of the present invention as many comparable param-
eters, sizes, ranges, and/or values may be implemented. 
FIG. 1 illustrates a mitral valve 100. As shown, the mitral 
valve 100 includes a mitral annulus 105, an anterior mitral 
leaflet 110, a posterior mitral leaflet 115, chordae tendineae 
120, and medial and lateral papillary muscles 135, 140. Mitra! 
annulus refers to the elliptical region of the valve leaflet 
attachment contiguous with the base of the left atrium. The 
mitral annulus 105 is composed of anterior mitral annulus 
125 and a posterior mitral annulus 130. The mitral annulus 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 illustrates a perspective view of a mitral valve and 
certain other components associated with a mitral valve. 
50 105 is saddle shaped with the basal portions of the saddle 
located medially and laterally. Attached to the anterior mitral 
annulus 125 is the anterior mitral leaflet 110 and attached to 
the posterior mitral annulus 130 is the posterior mitral leaflet 
FIG. 2 illustrates a spatial reference system based on nor-
mal papillary muscle position that the inventors used during a 55 
study of papillary muscle position. 
115. The regions where the anterior mitral leaflet 110 and the 
posterior mitral leaflet 115 meet are termed the lateral com-
missure 145 and the medial commissure 150. 
The various components of the mitral valve 100 depicted in 
FIG. 1 control blood flow within a heart between the left 
atrium and left ventricle of the heart. In a normal mitral valve, 
FIG. 3 illustrates a device to control the position of multiple 
papillary muscle including an annular ring according to some 
embodiments of the present invention. 
FIG. 4 illustrates a device to control the position of a 
papillary muscle including an annulus support anchor accord-
ing to some embodiments of the present invention. 
60 when the atrial pressure exceeds the ventricular pressure, the 
valve leaflets 110, 115 open in to the ventricle. When the 
ventricle pressure increases, the leaflets meet and close, cov-
ering the area of the valve annulus 105. Therefore, as shown 
FIG. 5 illustrates a device to control the position of a 
papillary muscle including an annular ring and an external 65 
restraint according to some embodiments of the present 
invention. 
in FIG. 1, the anterior mitral leaflet 110 and the posterior 
mitral leaflet 115 will open during systole to allow blood to 
flow through the mitral valve 100. Conversely, the anterior 
mitral leaflet 110 and the posterior mitral leaflet 115 will 
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overlap and close the mitral valve 100 to prevent regurgita-
tion, into the left atrium. As people age and due to other 
factors, the mitral valve 100 and its components can stop 
functioning correctly thereby allowing regurgitation of 
blood. 
As part of their discovery of the various embodiments of 
the invention discussed herein, the inventors performed sev-
eral studies. These studies led the inventors to conclude that 
controlling the position of papillary muscles of an atrioven-
tricularvalve can enable an abnormal atrioventricularvalve to 
have normal functional characteristics. With respect to a 
mitral valve, such normal functional characteristics include 
improved closure between valve leaflets 110, 115 (or leaflet 
malcoaptation) to help control, reduce, and eliminate regur-
gitation between the left atrium and left ventricle of the heart. 
In addition to discussing various embodiments of the present 
invention below, certain of the inventor's study results and 
methodologies are also provided to further explain concepts 
and details associated with various embodiments of the 
present invention. 
Discussion of Study Methodologies and Study Results 
The inventors studied seven human and four porcine valves 
using a left heart simulator with a standard atrial model. 
Variations in chordal force and mitral regurgitation due to 
papillary muscle displacement utilize a normal papillary 
muscle position as a reference for the study. The papillary 
muscles were displaced to eight different papillary muscle 
positions. FIG. 2 illustrates a spatial reference system based 
8 
chords controlling coaptation and especially those involved 
in the appropriate sealing of the valve are less sensitive to the 
changing environment. Therefore, the intermediate chords 
are less sensitive to changes in papillary muscle position than 
the basal chords, whereas the marginal chords are the least 
sensitive of all chordal types to papillary muscle position 
variations. 
These characteristics were clearly shown by the standard 
deviations of the forces of the chords when different papillary 
10 muscle positions were compared. In addition, the direction of 
displacement of the papillary muscles was directly related to 
which chord type presented altered tensions. For example, 
apical displacement affected tension on the secondary chords 
of both leaflets, whereas posterior displacement tended to 
15 reduce the force on chords which inserted into the posterior 
leaflet. The tensions on chords which inserted near the annu-
lus were affected by displacement of the papillary muscles in 
all directions. Apical displacement significantly increased the 
tension present on the anterior strut chord. When the papillary 
20 muscles are displaced apically, the coaptation geometry of the 
mitral valve changes. Thus, apical displacement generates 
tented leaflet geometries, and under a tented geometry, the 
intermediate chords restrict leaflet motion. 
The study results for the anterior strut chord showed that as 
25 apical displacement of the papillary muscles tented the leaf-
lets and significantly increased the load the anterior strut 
chord. The decrease in force when repositioning the papillary 
muscles from position 500 to position 505 was probably 
related to a redistribution of the load between chords. Poste-
on normal papillary muscle position that the inventors used 
during a study of papillary muscle. 30 rior papillary muscle displacement decreased the tension on 
the posterior intermediate chord by approximately 3 7%. This 
papillary muscle relocation shifted the coaptation line poste-
riorly, reducing the area of the orifice covered by this leaflet 
and decreasing the insertion angle ofthis chord. Both of these 
The reference for the displacements illustrated in FIG. 2 is 
the normal papillary muscle position. All papillary muscle 
displacements were symmetrical in the study; therefore both 
papillary muscles were displaced equally to reach each posi-
tion. All papillary muscle positions were constructed from 5 35 
mm vectorial displacements from the normal position in the 
apical, lateral, and posterior directions in the study. Illustrated 
in FIG. 2 is a displacement reference system 205 that shows 
the various displacement positions used by the inventors in 
their studies. The below table (Table I) summarizes the vec- 40 
torial compositions of the papillary muscles that the inventors 
used with the displacement reference system 205 illustrated 
in FIG. 2. 
changes reduced the resultant force vector. The increase in 
tension associated with position 500 is explained by the same 
tenting described for the anterior strut chord. 
Combined apical-lateral displacement induced a signifi-
cant increase in tension due to tenting of the leaflet and the 
stretching and redirection of the posterior intermediate chord. 
This effect was reduced in position 555 because of the pos-
terior motion associated with this position. The force on the 
anterior marginal chord and posterior marginal chord was 
relatively homogeneous for the different papillary muscle 
Papillary 
Muscle 
Position 
TABLE I 
Displacement (millimeters) 
Apical Lateral Posterior 
45 positions. As the marginal chords control coaptation in the tip 
of the leaflet, tension in them may be less sensitive to changes 
in papillary muscle position as the mitral valve is designed to 
operate in a highly dynamic environment. The tension on the 
posterior basal chord was highly sensitive to papillary muscle 
000 0 
005 0 
050 0 
055 0 
500 
505 
550 
555 
0 0 
0 
0 
0 0 
0 
0 
50 displacement. Posterior displacement reduced the tension on 
the posterior basal chord as it redirected the angle of the 
chord. This motion reduced the septa! lateral component of 
force, and thus reduced the overall resultant force. As chordae 
tendineae have a non-linear mechanical response to elonga-
55 tion, apical displacement increased peak systolic tension on 
the basal posterior chord because of pre-straining. A pre-
strained chord will be subjected to a higher tension for a 
similar strain during coaptation. Lateral displacement of the 
papillary muscles reduced the force on the basal posterior During the cardiac cycle, the mitral valve is held within a 
very dynamic environment which is described by annulus 
displacement, ventricular motion, and papillary muscle con-
traction. Within this environment, the basal chords maintain a 
relatively constant distance from the tips of the papillary 
muscles to the annulus, aiming to maintain overall valve 
geometry and isolating the motion of the leaflets from the 65 
surrounding environment movement. The geometrical and 
anatomical construct of the mitral valve must ensure that the 
60 chord. This reduction was probably due to a redistribution of 
the load with other chords. 
The commissural chord selected experiments inserted near 
the annulus and below the septa lateral midpoint of the valve 
(posterior section of the valve); therefore, trends in force 
variation due to papillary muscle displacement were similar 
to those present in the basal posterior chord. Similarly, pre-
straining increased the force on the basal posterior chord 
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during apical motion of the papillary muscles. In addition, 
both posterior and lateral relocation of the papillary muscles 
decreased the force on these chords. The relative contribu-
tions of these motions (lateral, posterior) to the force on the 
commissural chord should be different than the contributions 
to the force of the basal posterior chord because of their 
different angle and location of insertion on the valve. 
10 
Finally, positions associated with apical displacement 
(500, 505, 550, 555), showed clinically significant levels of 
mitral regurgitation (>20% ). Other positions associated with 10 
lateral or posterior displacement of the papillary muscle did 
not induce clinically relevant mitral regurgitation. Only posi-
tion 505 associated with both lateral and posterior displace-
ment showed an increase in regurgitation. 
apical posterior lateral papillary muscle displacement per-
formed in the inventor's study simulated this condition. 
Indeed, apical displacement was restricted by the chordae 
tendineae because of their stiffness. This is consistent with 
measurements by others, who observed that the distance 
between the tips of the papillary muscle and the mitral annu-
lus is relatively constant. Both the anterior and posterior 
mitral leaflets were restricted during systole with symmetri-
cal papillary muscle displacement. 
Symmetrical papillary muscle displacement induced the 
coaptation line to shift towards the ventricle parallel to the 
annulus plane, and produced leakage gaps and regurgitation 
in the central region of the valve. This is similar to the phe-
nomenon observed in patients with extensive myocardial inf-
The study results revealed the effects of papillary muscle 
displacement on the peak systolic tension present on different 
types of chordae tendineae. Apical motion increased peak 
systolic tension on the secondary chords, whereas chords on 
the posterior side of the valve were subject to a reduction in 
peak systolic tension after posterior motion of the papillary 
muscles. Chords which insert near the annulus were affected 
by lateral, posterior, and apical displacement of the papillary 
muscles. The study results also showed that variation in ten-
sion due to papillary muscle relocation decreased with 
increasing distance of chordal insertion from the mitral annu-
lus. Chords which insert nearthe annulus are the most sensi-
tive to variations in papillary muscle position, whereas chords 
which insert into the tip leaflet are the least sensitive to pap-
illary muscle relocation. Additionally, mitral regurgitation 
was associated with apical displacement of the papillary 
muscles, and therefore may also be associated with increased 
tension of the intermediate or basal chords. 
A second study on papillary muscle displacement was 
designed to elucidate the interaction between annular dilation 
and both symmetrical and asymmetrical papillary muscle 
displacement. The porcine mitral valves mounted in a normal 
sized annulus and in a normal papillary muscle position 
closed efficiently, with a central coaptation length of approxi-
mately 15.8±2.1 mm, and without echodetectable mitral 
regurgitation. With dilated mitral annuli and/or displaced 
papillary muscles, regurgitation occurred. The measured cen-
tral coaptation lengths decreased with annular dilation and 
papillary muscles displacement. Coaptation length reached 
its minimum value of approximately 0.4±0.5 mm while using 
the large annulus and under symmetrical papillary muscle 
displacement. 
15 arction, where the area of the roots of both papillary muscles 
may be affected, leading to subsequent relocation. Regional 
myocardial infarction produces local effects which may 
result in uneven papillary muscle displacement, especially if 
the area affected involves only one of the papillary muscles. 
20 Asymmetric papillary muscle displacement restricted leaflet 
motion on the tethered side of the valve. Commissural leaflets 
appeared to be more affected by papillary muscle displace-
ment, because they are shorter than the posterior and anterior 
leaflets, and are therefore characterized by a smaller coapta-
25 tion area. With a dilated annulus and under papillary muscle 
tethering, the commissural leaflets decreased their coaptation 
area and developed leakage gaps. Furthermore, tethering only 
one papillary muscle (i.e., asymmetric tethering) led the com-
missural leaflet on the opposite side of the valve to bulge 
30 towards the atrium during systole, as a result of relative slack-
ness in the chordae tendineae in this area of the valve. 
These observations, which describe irregular tenting and 
bulging of the leaflets, are consistent with observations in 
experiments using an in-vivo ovine model of acute infarction 
35 of the posterior left ventricular wall. Increased tension on one 
commissural side leads to an uneven coaptation with off-
centered gaps and consequently significant mitral regurgita-
tion on the tethered side of the valve, which is also consistent 
with clinical observations, where the regurgitation Jets were 
40 found on the side of the infarction. Ischemic myocardial 
infarction may also restrict anterior leaflet motion and gener-
ated posterior leaflet prolapse. 
Leaflet geometry during valve closure was affected by 
annular dilation and papillary muscle position. Symmetrical 
45 papillary muscle displacement caused leakage gaps in the 
central region of the coaptation line and subsequent regurgi-
tation. Asymmetric papillary muscle tethering caused teth-
ered side leakage gaps and moderate to severe regurgitation. 
Tenting and bulging of the commissural leaflets generated 
Mitra! regurgitation volume increased with annular dila-
tion and papillary muscle displacement. The volume reached 
approximately 18.5±10.2 ml with the large annulus under 
symmetrical papillary muscle displacement. Regurgitation 
volume correlated with central coaptation length 
(r=approximately 0.71). Asymmetric tethering of the poste-
rior papillary muscle led to mitral regurgitation volumes of 
approximately 4.1±1.9; 12.4±4.3; and 20.1±12.5 ml for the 
normal, medium, and large annuli, respectively. Asymmetric 55 
anterior papillary muscle tethering led to regurgitation vol-
umes of approximately 3.6±1.8; 10.5±3.5; and 19.6±9.9 ml 
for the normal, medium, and large annuli, respectively. 
50 vulnerable points for mitral regurgitation under these condi-
tions. In general under similar conditions of annular dilation 
asymmetric papillary muscle displacement induced larger 
regurgitation volumes than symmetric papillary muscle dis-
placement. 
In summary, the inventor's studies showed that papillary 
muscle displacement are associated with mitral regurgitation. 
Increased annular area reduces leaflet coaptation resulting in 
regurgitation. In addition papillary muscle displacement can 
produce leaflet malcoaptation and subsequent regurgitation. Increased distance between the anterior and posterior 
annuli in the dilated mitral annular model decreased leaflet 
coaptation length, shifting the coaptation line towards the 
edges of the leaflets. This describes how a larger orifice has to 
60 The inventors also found that the regurgitation due to papil-
lary muscle displacement was more severe when the papillary 
muscles are displaced asymmetrically. The inventors also 
discovered that apical displacement is an important determi-be covered by the same amount of tissue; therefore the over-
lapping of the leaflets is reduced. Clinical observations of 
extensive left ventricular infarction, or left ventricular dila- 65 
tion, have shown that both papillary muscles move in the 
radial direction away from the center of the left ventricle. The 
nant of regurgitation due to papillary muscle displacement. 
Apical displacement affects the tension on the intermediate 
chords restriction leaflet motion. Thus, controlling papillary 
muscle position was found to be a factor to correct mitral 
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regurgitation. Considering that there is a constant distance 
between the connnissural areas of the annulus and papillary 
muscles, this distance can be controlled by the below dis-
cussed various embodiments of the present invention to 
restore normal valve functions to an abnormal functioning 
atrioventricular valve. 
Discussion Of Embodiments 
Turning now specifically to the other figures, FIG. 3 illus-
trates a device 300 that includes papillary muscle support 
structures to control papillary muscle position according to 
some embodiments of the present invention. The device 300 
is configured to enable control of a distance along line L 
between the annulus and the tip of the papillary muscles. The 
distance along line Lis at times referred to herein as the apical 
distance between papillary muscles and an associated atrio-
ventricular valve. 
As shown in FIG. 3, the device 300 has various compo-
nents. These components can include an annuloplasty device 
305, a first support structure 310, a second support structure 
315, a first papillary muscle pad 320, a second papillary 
muscle pad 325, a first ventrical wall pad 330, and a second 
ventrical wall pad 335. As shown, the two support structures 
310, 315 are disposed and coupled between the annuloplasty 
device 305 and a respective papillary muscle pad and ventri-
cal pad. More specifically, the first support structure 310 is 
coupled between the annuloplasty device 305, and the first 
papillary muscle pad 320 and the first ventrical wall pad 330. 
Similarly, the second support structure 315 is coupled 
between the annuloplasty device 305, and the first papillary 
muscle pad 325 and the first ventrical wall pad 335. As dis-
cussed below in greater detail, other embodiments may utilize 
a single support structure, may not include an annuloplasty 
device, or may utilize different mechanisms to attach to an 
annuloplasty device and a papillary muscle. 
Preferably the device 300 enables the support structures 
310, 315 to move so that the length of line L can vary. For 
example, the papillary muscle pads 320, 325 and the ventrical 
wall pads 330, 335 can be adapted to enable movement of the 
support structures 310, 315 such that the length of the support 
structures can be adjusted or varied. According to some 
embodiments, one or both of the papillary muscle pads 320, 
325 and ventrical wall pads 330, 335 can include locking 
mechanisms or other pressure mechanisms to enable the dis-
tance between a papillary muscle and an annulus to be 
adjusted and fixed at a certain length. For example, the pads 
can comprise a clamping or pin mechanism that will fix the 
support structures 310, 315 in a static position. The move-
ment of the papillary muscle relative to the annulus can alter 
or change the geometric shape of valve leaflets to control, 
reduce, and eliminate regurgitation. 
The annuloplasty device 305 can have various characteris-
tics. Indeed, according to some embodiments, the annulo-
plasty device 3 05 can have a proximal ring 3 07. The proximal 
ring 307 may be rigid, flexible, complete, partial, or comprise 
multiple links. The proximal ring 307 may also be con-
structed of a biocompatible material or of a non biocompat-
ible material covered by a biocompatible layer. For example, 
the proximal ring 307 may be constructed of a biocompatible 
metal or biocompatible polymer. The proximal ring 307 may 
be covered by a suturing layer which will allow it to be 
attached using sutures to the annulus. The proximal ring 307 
may be attached on or to the annulus of an atrioventricular 
valve using clamps, hooks, sutures, or other anchoring 
mechanisms. 
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or temporarily be coupled to or engage the support structure 
310, 315. For example, the support structures 310, 315 can be 
manufactured integrally with the annuloplasty device 305 to 
form a unitary device or the supports structures 310, 315 can 
be manufactured separately from the annuloplasty device 
305. For embodiments where the support structures 310, 315 
are not permanently coupled to the annuloplasty device 305, 
the support structures 310, 315 can include attachment mem-
bers that enable the support structures 310, 315 to connect to 
10 any annuloplasty device. This advantageous feature of certain 
embodiments of the present invention enables use with an 
annuloplasty device already deployed or implanted within a 
patient, or an annuloplasty device manufactured by a different 
manufacturer. Alternatively, the support structures 310, 315 
15 can comprise clamps to enable the support structures 310, 315 
to clamp onto an annuloplasty device 305. Other techniques 
for coupling support structures to an atrioventricular valve 
annulus or annuloplasty device are discussed below. 
The support structures 310, 315 of the device 300 can also 
20 have various characteristics. As mentioned above, and as 
shown in FIG. 3, the support structures 310, 315 can be 
connected to a papillary muscle and the annuloplasty device 
305. Alternatively, the support structures 310, 315 may be 
connected between a papillary muscle and an annulus of an 
25 atrioventricular valve or a wall of an atrioventricular valve. 
The support structures 310, 315 may be an elongated rod, 
wire, suture, or many other similar tension members. The 
support structures 310, 315 may be constructed of numerous 
materials, including but not limited to, a biocompatible metal, 
30 biocompatible polymer, biocompatible silk, other biocom-
patible materials, collagen, bio-engineered chords, or other 
bio-engineered materials. The support structures 310, 315 
can also be slidably coupled to or otherwise interact with the 
pads 320, 325, 330, 335 enabling the apical distance L to be 
35 adjusted and fine tuned after implantation of the device 300. 
The pads 320, 325, 330, 335 of device 300 can have various 
characteristics. More specifically, the papillary muscle pads 
320, 325 preferably enable the support structures 310, 315 to 
pass through (or penetrate) a papillary muscle so that the 
40 papillary muscle is not damaged and so that the support 
structures 310, 315 do not entangle among the several chords 
associated with a papillary muscle. As shown, the papillary 
muscle pads 320, 325 can be attached or secured to a tip of a 
papillary muscle. In other embodiments, the papillary muscle 
45 pads 320, 325 may have other configurations that allow the 
papillary muscle pads 320, 325 to be attached or secured 
along the exterior of or proximate the base of a papillary 
muscle. An exemplary configuration can include a donut 
shaped papillary muscle connection device. The ventrical 
50 wall pads 330, 335 preferably provide a support on the exte-
rior of a ventrical wall so that a support structure can be 
securedly affixed to the ventrical wall pads 330, 335. The 
ventrical wall pads 330, 335 can have various lengths. 
The pads 320, 325, 330, 335 of device 300 can connect to 
55 the support structures 310, 315 in numerous configurations. 
According to some embodiments, the attachment pads 320, 
325, 330, 335 can include an aperture for receiving the sup-
port structures 310, 315. Such a configuration enables the 
support structures 310, 315 to move relative to the attachment 
60 pads 320, 325, 330, 335 to enable the apical distance L to be 
adjusted thereby controlling the position of a papillary 
muscle relative to an associated annuloplasty device or annu-
lus. 
As mentioned above, the support structures 310, 315 can be 65 
coupled to the annuloplasty device 305 according to some 
embodiments. The annuloplasty device 305 may permanently 
FIG. 4 illustrates a device 400 to control the position of a 
papillary muscle including an annulus support anchor accord-
ing to some embodiments of the present invention. As shown, 
device 400 generally includes an annulus anchor 405, a sup-
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port structure 410, and a papillary muscle attachment system 
415. As shown, the annulus anchor 405 is coupled to an 
annulus 420 of an atrioventricularvalve 425, and the papillary 
muscle attachment system 415 is coupled to a papillary 
muscle 430 of the atrioventricular valve 420. The device 400 
can enable the apical distance L between the annulus 420 and 
the papillary muscle 430 to be adjusted thereby controlling 
the geometrical shape of the annulus 420 and its associated 
leaflets (not shown). 
As shown, the support structure 410 is disposed between 
the annulus 420 and the papillary muscle 430. In some 
embodiments, the support structure 410 may directly anchor 
to the annulus 420 of the atrioventricular valve 420 (without 
the need for an annuloplasty ring) and in other embodiments, 
the support structure 410 can be coupled to an annuloplasty 
ring. The annulus anchor 405 can be many attachment mecha-
nisms that enable the support structure 410 to be fixedly 
secured to the annulus 405. For example, such attachment 
mechanisms can include, but are not limited to, a single or a 
plurality of hooks, clamping surfaces, or an umbrella type 
device. Still yet, the annulus anchor 405 can have divergently 
extending arm members, such as arm members 406, 407, that 
can extend at least partially around the perimeter of the annu-
14 
Although the movement of the support structure 410 is dis-
cussed as movement based from the papillary muscle 430 
other embodiments may utilize movement based from one or 
more of the annulus 420 and the annulus anchor 405. 
One or both of the first pad 435 and the second pad 440 can 
also have locking mechanisms. A locking mechanism enable 
the pads 435, 440 to lock at a certain point along the axis of the 
support structure 410. Sample locking mechanisms can 
include, but are not limited to, threaded screw devices, pin 
10 locking devices, detent mechanisms, or many other mecha-
nisms capable of applying pressure to the support structure 
410. Advantageously, the locking feature enables the device 
400 to be adjusted to fix the apical distance L to provide an 
optimal change to the morphology of the annulus 420 thereby 
15 enabling specific control and position of the papillary muscle 
430 with respect to the annulus 420. 
FIG. 5 illustrates a device 500 to control the position of a 
papillary muscle according to some embodiments of the 
present invention. The device 500 generally includes an annu-
20 lar ring 505, a support structure 510, a papillary muscle 
attachment system 515, and a restraint 520. While the 
restraint 520 is illustrated as an external restraint (positioned 
outside a valve), the restraint 520 may also be an internal 
restraint positioned within a valve. For brevity, certain details lus 420. The arm members 406, 407 can have variable flex-
ibilities to enable the support structure 410 to attach at various 
places along the annulus 405 or attach to various types of 
annuloplasty devices. The annulus anchor 405 may be per-
manently connected to the support structure 410 in some 
embodiments or may be detachably affixed such that the 
annulus anchor 405 and the support structure 410 can be 30 
detached and reattached numerous times. 
25 of the annular ring 505, the support structure 510, and the 
papillary muscle attachment system 515 are not discussed in 
detail with device 500 as these items can have characteristics 
and details similar to the corresponding named components 
discussed herein. As shown in FIG. 5, the annular ring 505 is 
coupled to an annulus of a valve and the papillary muscle 
attachment system 515 enables a support structure 510 
As shown, the support structure 410 is also connected to the 
papillary muscle 430 via the papillary muscle attachment 
system 415. The papillary muscle attachment system 415 can 
comprise multiple pads, such as a first pad 435 and a second 
pad 440, enabling the papillary muscle attachment system 
415 to be fixedly secured to or encompass the papillary 
muscle 430. For example, the firstpad435 and the second pad 
440 can be sutured proximate the papillary muscle 430. Alter-
natively, the pads 435, 440 may not be secured directly to the 
papillary muscle 430 and may be slidably coupled to the 
support structure 410. Still yet, one or more of the pads can 
lockably engage the support structure 410 to a certain length 
to adjust the apical distance between the annulus 420 and the 
papillary muscle 430. This configuration can also enable the 
pads 435, 440 to be axially moved along the axis of support 
structure 410 to encompass the papillary muscle 430 to alter 
the shape of the papillary muscle 430. 
The papillary muscle system 415 preferably enables move-
ment of the papillary muscle 430 relative to the annulus 420. 
This movement can adjust the apical distance L and enables 
the geometry of the annulus to be altered in a manner to 
control, reduce, or eliminate regurgitation that may be asso-
ciated with atrioventricular valve 425. The apical movement 
can occur in various manners according to the various 
embodiments of the present invention. For example, the sec-
tion of the support structure 410 disposed between the annu-
lus 420 and the papillary muscle 430 can be adjusted by 
moving the first pad 435 and the second pad 440 along the axis 
extending from the annular ring 505 to be fixedly attached to 
a papillary muscle. The restraint 520 partially blocks from 
view the papillary muscle attachment system 515 since the 
35 restraint 520 is an external restraint. 
The annular ring 505 can have various characteristics. For 
example, the annular ring 505 may be a flexible ring, a rigid 
ring, or a multilink ring. The annular ring 505 may be com-
plete or partial. Also, the ring 505 may have a saddle height to 
40 commissural ratio between approximately 0% and approxi-
mately 30%. In one preferred embodiment, the annular ring 
505 can be composed of titanium wire, stainless steel, Nitnol, 
other biocompatible metals, or combinations thereof. In yet 
other embodiments, the annular ring 505 may be constructed 
45 of a biocompatible polymer. The annular ring 505 may be 
covered by a suturing cuff when coupled to an annulus of a 
valve. The cuff material may be Dacron or other biocompat-
ible suture support polymers. The annular ring 505 may be 
attached to a valve annulus through suture, clamps, titanium 
50 clips, hooks, or many other anchoring mechanisms. 
The annular ring 505, like rings of other embodiments, can 
be deployed using a variety of methods. For example, the 
annular ring 505 may be collapsed and delivered through a 
catheter endovascularly or through a long arm thorocoscopi-
55 cally. The annular ring 505, if partial, may be extended within 
a lumen of a catheter during delivery. If the annular ring 505 
is composed of a series of links, it may be reversibly opened 
to deliver it using less invasive (or minimally invasive) meth-
ods according to some embodiments of the present invention. 
The support structure 510 can also have a variety of char-
acteristics. For example, the support structure 510 can be 
permanently attached to the annular ring 505. The support 
structure 510 can also be retractable, and anchored onto the 
annular ring 505 through a latching, locking, or screw mecha-
of the support structure. The first pad 435 and the second pad 60 
440 can have interior apertures located within the first pad 
435 and the second pad 440 that allow the support structure 
410 to slidably pass through the first pad 435 and the second 
pad 440. Once the length of the support structure 410 has been 
adjusted to an appropriate amount that corresponds to an 
optimal apical distance modification, the pads 435, 440 can 
65 nism. Other mechanisms to attach or couple the support struc-
ture 510 to the annular ring 505 include screws, clamping, 
knots, and clips. In one preferred embodiment, the support be used to fix the support structure the appropriate amount. 
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structure 510 can be a single or a plurality of elongated rods. 
The support structure 510 may be rigid, flexible, straight, or 
curved. Additionally the support structure 510 may be formed 
of a single or plurality of component materials. For example, 
the support structure 510 can be formed of a plurality of thin 
metal wires. The support structure 510 can be constructed 
using various materials, included but not limited to, titanium, 
stainless steel, biocompatible alloys, biocompatible poly-
mers, gortex, silk, or other biocompatible materials. 
As shown in FIG. 5, the device 500 includes a single 10 
support structure 510 and use ofan annular ring 505. It should 
be understood, however, that other embodiments of the 
present invention encompass using multiple support struc-
tures 510 and not using an annular ring 505. For example, 
some embodiments comprise a single or a plurality of bio- 15 
compatible support structures 510 which extend between a 
valve annulus and a papillary muscle or a ventricular wall. 
Thus, one end a support structure 510 can comprise an 
anchoring mechanism that can couple the support structure 
510 to a valve annulus. The anchoring mechanism may con- 20 
sist of a series of hooks, clamps, expanding umbrella, or a 
memory alloy mesh. 
FIG. 5 also illustrates how the restraint 520 can be provided 
around the exterior of an atrioventricular valve. The restraint 
520 can be used to help control the lateral distance between 25 
papillary muscles (e.g., medial and lateral papillary muscles) 
and also in reshaping the exterior of a valve as it might grow 
or expand. This lateral distance is labeled as line DFMin FIG. 
5. Controlling the lateral distance can assist in controlling the 
apical distance between papillary muscles and an associate 30 
valve annulus. It should be understood that a lateral distance 
control mechanism can also be used in accordance with other 
embodiments of the present invention. Other features of the 
restraint 520 can include restricting lateral growth of a valve 
wall by applying a radially inward force to the valve wall. 35 
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an annular ring 605, a support structure 610, and a ventrical 
wall pad 615. In this embodiment, the support structure 610 
and the ventrical wall pad 615 are adapted so that the papillary 
muscle 620 is not penetrated by the support structure 610. 
Such a configuration may be advantageous when penetration 
of a papillary muscle may not be beneficial for a patient or 
when movement of a papillary muscle with respect to the 
support structure 610 may cause the device 600 to function 
improperly. 
Because of the placement of the support structure 610 
around the exterior of the papillary muscle 620, the shape of 
the ventrical wall pad 615 can be modified. As shown in FIG. 
6, the ventrical wall pad 615 is shown to extend below the 
papillary muscle 620 such that it cups the exterior valve wall 
proximate the papillary muscle 620. Also, as shown, the ven-
trical wall pad 615 has a bottom end 625 that is curved to cup 
the exterior valve wall. Such configuration of the ventrical 
wall pad 615 ensures that pressure applied to the valve wall 
does not harm the valve wall or papillary muscle 620 and 
sufficiently controls the position of the papillary muscle 620. 
As with other embodiments of the present invention, 
device 600 is preferably adapted so that the apical distance L 
between the annular ring 605 and the papillary muscle 620 
can be adjusted. Adjusting this distance can occur by moving 
or sliding the ventrical wall pad 615 along the axis of the 
support structure 610. The ventrical wall pad 615, therefore, 
preferably includes a locking mechanism that enables the 
ventrical wall pad 615 to lock onto a certain point along the 
axis of the support structure 610. This advantageous features 
enables an optimal apical distance L to be obtained after 
deployment of device 600. For example, after device 600 is 
surgically deployed within a patient, the apical distance L can 
be modified such that regurgitation can be reduced or elimi-
nated. 
FIG. 7 illustrates a device 700 to control a position of a 
papillary muscle using support structures having variable 
lengths according to some embodiments of the present inven-
tion. Generally, the device 700 comprises an annular ring 705, 
two support structures 710, 711 and an attachment system 
The restraint 520 can have additional characteristics. For 
example, the restraint 520 can be attached at multiple points 
along the exterior of a valve wall to control the distance 
between medial and lateral papillary muscles. As mentioned 
above, the restraint 520 can also be provided internally within 
a valve such that it can be disposed between medial and lateral 
papillary muscles. For example, in one configuration, an 
internal restraint can be a suture or other tension member that 
is coupled to the medial and lateral papillary muscles or at 
positions along the valve wall proximate the medial and lat-
eral papillary muscles. The restraint 520 can be made from 
many materials, and can comprise one or more materials, 
including but not limited to, polymer materials, a metallic 
mesh, and cloth materials. 
40 715. The support structures 710, 711 are disposed between 
and coupled to the annular ring 705 and the attachment sys-
tem 715. As shown, the attachment system is attached to 
papillary muscles 720. In other embodiments the attachment 
system 715 can be coupled to a ventricular wall. Also, the 
The restraint 520 can also have an adjustable length. For 
example, the ends of the restraint 520 may be fixedly secured 
to the papillary muscle attachment system 515. Adjustment of 
the length of the restraint 520 can occur when one or both 
ends of the restraint 520 are moved relative to the papillary 
muscle attachment system 515 thereby having a cinching 
effect to decrease the lateral distance DPM" Also, in some 
embodiments, the papillary muscle attachment system 515 
can comprise a locking or securing mechanism enabling the 
length of the restraint 520 to be fixed after an optimal length 
has been obtained. For example, a device can be at least 
partially located within a papillary muscle to enable the 
length of the restraint 520 to be adjusted and then clamped or 
pinned to have a certain length. 
FIG. 6 illustrates a device 600 to control a position of a 
papillary muscle including a support structure that does not 
penetrate a papillary muscle according to some embodiments 
of the present invention. Generally, the device 600 comprises 
45 attachment system 715 may anchor to a ventricular wall by 
being coupled to inner or outer surfaces of a ventricular wall. 
The attachment system 715 may move axially along the 
length of the support structures 710, 711 to control the apical 
distance L between the papillary muscles 720 and the annulus 
50 ring 705. 
The attachment system 715 can also comprise other com-
ponents. These components can include a tension member 
725 disposed between opposing end members 730, 735. The 
end members 730, 735 can each comprise apertures to receive 
55 the support structures 710, 711. This configuration enables 
the end members 730, 735 to compress the tension member 
725 as the end members 730, 735 are moved along the axis of 
the support structures 710, 711. Advantageously, this con-
figuration can also restrict axial movement of the papillary 
60 muscles 720 and/or can enable the length of the papillary 
muscles 720 to be controlled. Such a configuration may be 
desired ifone of the papillary muscles 720 is damaged or does 
not properly function. According to some embodiments, the 
position of the attachment system 715 along the axis of the 
65 support structure may also be controlled externally, or outside 
of the heart. For example, a surgeon could insert an adjust-
ment tool via minimally invasive process into a patient (with 
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a beating heart) and use the tool to adjust, or fine tune, the 
length of the support structures 710, 711 to control and elimi-
nate regurgitation. 
18 
saddle ring 805 and the exterior pads 820, 840 in turn modifies 
the apical distance between the valve's annulus and papillary 
muscles. Apical distance modification can result in reshaping 
the morphology and geometry of the valve's annulus thereby 
enabling the leaflets of the annulus to move closer together. 
The support structures 810, 815 can have interiors that 
enable the length of the support structures to be modified. For 
example, support structure 810 can have an interior 830 with 
detent members that enable movement and locking of the 
In other embodiments, the attachment system 715 can be 
controlled remotely via a remote adjuster outside of a 
patient's body. Such a remote adjuster may transmit radio 
frequency signals, microwave signals, or other non-visible 
energy to activate or instruct the attachment system to adjust 
the length of on or more of the support structures 710. Thus, 
the attachment system 715 may comprise a signal receiver or 
transmitter to receive such instructions or transmit status 
information to a remote adjuster about the attachment system 
715 or the patient. The attachment system 715 can also be 
used to decrease or increase via remotes means the length of 
the papillary muscles 720 by compressing the tissue between 
the tip of the papillary muscle 720 and a corresponding ven-
tricular wall. 
10 interior with corresponding apertures when a force is applied 
to an axial force interface member 825. For example, the axial 
force interface member can be a suture or a wire and when 
subjected to an axial force, the length of the support structure 
810 can be reduced so that the annulus saddle ring 805 and the 
15 exterior pad 820 are moved closer together. 
Similarly, support structure 815 can have a threaded inte-
rior that enables rotation of one end of the support structure 
815 to be rotated to adjust the length of the support structure 
815. This threaded interior configuration 830 can enable the 
As mentioned above, the attachment system 715 may move 
axially along the length of the support structures 710, 711. To 
enable this advantageous feature, the attachment system 715 
may comprise adjustable and lockable mechanisms, such as a 
first exterior pad 740 and a second exterior pad 742. As 
shown, the first exterior pad 740 is disposed on the exterior 
wall of the illustrated valve. The second exterior pad 7 42 has 
a first portion that is disposed on the exterior wall of the 
illustrated valve and a second portion that is partially dis-
posed within the papillary muscle. 
20 length of the support structure 815 to be increased and 
decreased. According to some embodiments, support struc-
ture 83 0 may have a lever 845 at one end corresponding to pad 
840 and rotation of the lever 845 may cause the length of the 
support structure 815 to change. In other embodiments, a 
25 screw can be used in the place of the lever 845 and rotation of 
the screw can cause the length of support structure 815 to be 
modified. 
As shown in the close up illustrations of the pads 740, 742, 
they have features enabling the pads 740, 742 to lockably 
engage the support structures 710, 711. For example, the first 30 
pad 740 can have a notched interior aperture to receive a 
detent member formed on the support structure 710. An axial 
force applied to the support structure 710 can move detent 
member of the support structure 710 along the notched inte-
rior aperture. Also, the second pad 742 can have a pin clamp 35 
that lockably engages the support structure 711. The pin 
clamp can have a shaft to receive the support structure and a 
pin 7 43 that can be pushed toward and clamp the support 
structure. As the pads 740, 742 illustrate, some embodiments 
of the present invention can have support structure length 40 
adjustment mechanisms proximate papillary muscles. 
The support structures 810, 815 can also have certain inter-
nal flexibility characteristics. For example, the support struc-
tures 810, 815, as illustrated, can have internal spinal struc-
tures that enable the support structures to flex inward toward 
each other. Also, the support structures 810, 815 can have 
internal spinal structures that do not permit the support struc-
tures to flex away from each other. In other embodiments, the 
support structures 810, 815 can restrict lateral motion from 
one or more of the atrial or ventricular sides within a heart's 
mitral valve. Such an advantageous feature can, for example, 
aid in preventing growth of a heart's ventricle valve wall thus 
enabling the support structures 810, 815 to assist in control-
ling the position of one or more papillary muscles. 
Exemplary internal spinal structures can comprise a unidi-
rectional bending structure. This type of bending structure 
can comprise a plurality of internal components that taper 
away from the non-flexing direction. By tapering in the direc-
tion of the flexing direction, the internal spinal structures 
enable the support structure 810, 815 to compress. In one 
configuration, the plurality of internal components can gen-
erally have a triangular shape. In another configuration, the 
internal components can have a cross-section shaped as a "T". 
FIG. 8 illustrates a device 800 to control a position of a 
papillary muscle using internally threaded support structures 
according to some embodiments of the present invention. 
Device 800 generally comprises a first support structure 810, 45 
and a second support structure 815. The device 800 may also 
comprise annular saddle ring 805 in accordance with some 
embodiments of the invention. The device 800 can be 
deployed in an atrioventricular valve to control, reduce, and 
eliminate mitral regurgitation associated with the atrioven-
tricular valve by reducing the apical distance between the 
atrioventricular valve's annulus and papillary muscles. The 
annular saddle ring 805 can be sutured or otherwise attached 
50 Advantageously, restricting the support structure from flex-
ing can aid in shaping a valve wall and also implanting the 
device 800 within a patient. 
to the annulus, and the support structures 810, 815 can be 
extended in a valve to the valve's papillary muscles. The 
support structures 810, 815 can be coupled to the annular 
saddle ring 805 via clamps 815, 835 or many other anchoring 
or coupling mechanisms. The support structures 810, 815 
may be covered with a biocompatible material (such as Gore-
tex) and pierce or penetrate through the valve's papillary 
muscles and connect to exterior pads 820, 840 located outside 
of the valve's muscle wall. 
The support structures 810, 815 may also comprise internal 
security characteristics. As the support structures 810, 815 
55 may fracture or break, a security wire may be disposed within 
the support structures 810, 815. The security wire may trans-
verse the entire interior length of the support structures 810, 
815. Advantageously, a security wire can hold together or 
collocate any fracture support structure 810, 815 pieces 
60 because they will be disposed generally around the security 
Wife. 
The support structures 810, 815 can be adapted such their 
lengths can be adjusted. Adjustment of the lengths of the 
support structures 810, 815 can be utilized to vary the distance 65 
between the annular saddle ring 805 and the exterior pads 
820, 840. Variation of this distance between the annular 
FIG. 9 illustrates yet another device 900 to control a posi-
tion of a papillary muscle according to some embodiments of 
the present invention. The device 900 enables adjustment of 
the position of two papillary muscles of the mitral valve 
through the atrium 901 with an adjustment tool 902. Gener-
ally, the device 900 comprises an annular ring 905 coupled to 
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papillary muscles A, B via sutures 915, 916 as shown in FIG. 
9. The device 900 also comprises adjustment mechanisms 
909, 910, papillary muscle pad 920, and ventricle wall pad 
925. The adjustment mechanisms 909, 910 can be used to 
adjust the length of the sutures 915, 916. Adjusting the length 5 
of the sutures 915, 916 can change the position of the papil-
lary muscles A, B such that they are closer to the annular ring 
905 and the annulus of the mitral valve. The adjustment 
mechanisms 909, 910 may be situated proximate the annulus, 
the papillary muscles A, B, or both such that adjustment to the 10 
length of the sutures 915, 916 can be performed in multiple 
locations. 
In some embodiments, adjustment mechanisms 909, 910 
may be remotely adjusted from outside of the body. For 
example, a remote adjuster (not shown) can be used to acti- 15 
vate the adjustment mechanisms 909, 910. The remote 
adjuster may transmit radio frequency signals, microwave 
signals, heat energy, or other invisible energy to the adjust-
ment mechanisms 909, 910. The adjustment mechanisms 
909, 910 can receive such items and, in response, automati- 20 
cally activate the adjustment mechanisms 909, 910 to adjust 
the length of the sutures 915, 916. Also, the adjustment 
mechanisms 909, 910 may transmit status information out-
side of the body to inform about the status of the patient, 
device 900, adjustment mechanisms 909, 910, and/or the 25 
sutures 915, 916. 
The components of device 900 can be implanted within a 
mitral valve to reduce, control, and eliminate mitral valve 
regurgitation. The annular ring 905 can be sutured to the 
annulus of the mitral valve. The annular ring 905 can be used 30 
to change the shape of the annulus and may not be used in all 
embodiments. The adjustment mechanisms 909, 910 can be 
securedly coupled to the annular ring 905. In this embodi-
ment, the adjustment mechanisms are clamped to the annular 
ring 905. The adjustment mechanism 909, 910 preferably 35 
include internal devices that enable the length of the sutures 
915, 916 to be altered. Also, as shown, both of the adjustment 
mechanisms are located proximate the atrium of the illus-
trated mitral valve so that they can be adjusted through the 
atrium. For example, an adjustment tool 902 can be inserted 40 
through the atrium 901, as shown, to adjust the length of 
sutures 915, 916. Having the adjustment mechanisms 909, 
910 located proximate the atrium 901 advantageously 
enables access to the adjustment mechanisms 909, 910 during 
surgery or post-operative procedures. In other embodiments, 45 
the adjustment mechanisms can be located proximate to one 
or both of the papillary muscles A, B. 
As shown in the close up view of adjustment mechanism 
910, an adjustment mechanism according to certain embodi-
ments of the present can comprise various components. As 50 
shown, the adjustment mechanism 910 can generally include 
a clamp 911, a housing 912, an internal threaded bolt 913, and 
20 
internal thread nut 914 can be disposed within the housing. 
The internal thread nut 914 can be interlocked or in commu-
nication with the internal thread bolt 913. As shown, the 
internal thread nut can be situated proximate and between 
opposing inner walls of the housing 912. Rotation of the 
internal thread bolt 913 causes the internal thread nut 914 to 
move along the length of the internal thread bolt 913. In some 
embodiments, the internal thread nut 914 may be adapted to 
between approximately 0.1 centimeters to approximately 5 
centimeters. Also, the internal the internal thread bolt 913 and 
the internal thread nut 914 may have very fine thread pitch 
counts to enable precise specific movements thereby trans-
lating into very precise changes in the length of the suture 
916. 
FIG. 9 also illustrates a specific placement of the papillary 
muscle pad 920 which can be utilized in accordance with 
some embodiments of the present invention. The papillary 
muscle pad 920 can be used to attach the suture 915 to pap-
illary muscle A. The papillary muscle pad 920, as shown, can 
be a collar-type device situated proximately around the exte-
rior of the base of papillary muscle A. Alternatively, the 
papillary muscle pad 920 may be located at other positions 
along the exterior of or at the tip of papillary muscle A. In this 
embodiment, the papillary muscle pad 920 is located in the 
interior of the mitral valve so that surrounding areas of the 
heart are not affected, but in other embodiments, the papillary 
muscle pad 920 may be located outside of the mitral valve 
proximate papillary muscle A. 
Device 900 also illustrates how a ventrical pad (ventrical 
wall pad 925) may be disposed or positioned on the exteriorof 
the mitral valve according to some embodiments of the 
present invention. Indeed, as shown, the ventrical wall pad 
925 is along the exterior of the mitral valve proximate papil-
lary muscle B. The ventrical wall pad 925 can be sutured or 
otherwise attached to the exterior wall of the mitral valve at 
this position. Alternatively, the ventricle wall pad 925 may be 
affixed in place via the suture 916. The ventricle wall pad 925 
can have multiple apertures to receive suture 916. Adjustment 
of the length of the suture 916 by reduction can result in 
cinching effect on papillary muscle B by a force applied to the 
ventrical wall pad 925. This cinching effect along with a 
reduction in the length of the suture 916 can control the apical 
position of the papillary muscle B, and move the papillary 
muscle B closer to the annulus of the mitral valve. 
As shown in FIG. 9, the sutures 915, 916 generally couple 
the annulus of the mitral valve to the papillary muscles A, B. 
More specifically, the sutures 915, 916 connect the adjust-
ment mechanisms 909, 910 (which are coupled to the annu-
lus) to the pads 920, 925 (which are coupled to the papillary 
muscles A, B). The sutures 915, 916 are shown in a looped 
configuration, wherein the sutures 915, 916 are looped 
around or through the pads 920, 925 and the ends of the 
sutures 915, 916 are connected to the adjustment mechanisms 
909, 910. In other embodiments, the sutures 915, 916 may not 
an internal thread nut 914. The internal thread nut 914 can 
include attachment points so that the suture 916 can be 
securedly attached to the adjustment mechanism 910. The 
clamp 911 enables the adjustment mechanism 910 to be 
securedly attached to an annulus or annuloplasty device. 
As shown, the housing 912 houses the internal threaded 
bolt 913 and the internal thread nut 914. The internal thread 
55 be looped. Alternatively, other support members can be used 
in the place of or in concert with the sutures 915, 916, includ-
ing, but not limited, to wires, elongated rods, biocompatible 
metal, biocompatible polymer, biocompatible silk, other bio-
bolt 913 can be countersunk into the housing 912. The inter- 60 
nal thread bolt 912 can also be rotatably affixed to the housing 
912 so that the internal thread bolt 919 can rotate within the 
housing 912. In this exemplary embodiment, the internal 
threaded bolt 913 can have a head to communicate with or that 
corresponds to adjustment tool 902. This enables the adjust- 65 
ment tool 902 to transfer a mechanical torque force to the 
threaded bolt 913 for rotation of the threaded bolt 913. The 
compatible materials, collagen, bio-engineered chords, or 
other bio-engineered materials. 
FIG. 10 illustrates a device 1000 to control a position of a 
papillary muscle using a compression force according to 
some embodiments of the present invention. The device 1000 
generally comprises an interior pad 1005, a support structure 
1010, an exterior pad 1015, a tension member 1020, and a 
tension control member 1025. As shown, the interior pad 
1005 can be proximate a tip 1030 of the papillary muscle 
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1035. The support structure 1010 can extend from the interior 
pad 1005 through the papillary muscle 1035 to the exterior of 
a valve wall 1040. The exterior pad 1015 can be positioned 
proximate the exterior of the valve wall 1040 and the tension 
member 1025 can be disposed between the exterior pad 1015 
and the tension control member 1025. The support structure 
1010 can be coupled to one surface of the interior pad 1005, 
and be placed within apertures located within the exterior pad 
1015 and the tension control member 1025. 
The length of papillary muscle 1035 can be controlled 
using the device 1000. For example, tension control member 
1025 can be adjusted to move closer to the interior pad 1005 
and such movement can decrease the length of the support 
structure 1010 between interior and exterior pads 1005, 1015. 
This decreased length in tum can compress the papillary 
muscle 1035 in a manner that can control the tip 1030 of the 
papillary muscle 1035 relative to an associated annulus. 
The device 1000 can have various applications according 
to embodiments of the present invention. The device 1000 can 
be used as a stand alone device or in conjunction with a device 
such as that illustrated in FIG. 4 with a single support struc-
ture. In such a configuration, the devices 400, 1000 can form 
a system which can compress a first papillary muscle to 
control the position of a valve annulus in addition to apically 
adjusting a second papillary muscle. The device 1000 can also 
be used to control the length or shape of a papillary muscle in 
some embodiments. 
FIG. 11 illustrates a device 1100 to control a position of a 
papillary muscle using a compression force according to 
some embodiments of the present invention. The device 1100 
is similar in operation to the device 1000 illustrated in FIG. 
10, so for brevity the same reference numerals are used in 
FIG. 11 for corresponding features shown and described 
above with reference to FIG. 10. One difference between FIG. 
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a surgeon so that a papillary muscle control device can be 
deployed or implanted within the patient's heart. The method 
1200 may also be performed on a beating heart and in such an 
instance and bypass of the heart may not occur. 
Next, the papillary muscle control device can be deployed 
within a patient's heart in an effort to control, reduce, and 
eliminate regurgitation. The papillary muscle control device 
can be one of the exemplary embodiments discussed above, 
such as those illustrated in FIGS. 2-11. The papillary muscle 
10 control device may be implanted in a variety of manners and 
the implantation may depend on the utilized surgical proce-
dure, health of the patient, or other factors. For example, and 
according to the method 1200, that papillary muscle control 
device may be attached (or anchored) to at least one of a valve 
15 annulus or an annuloplasty device at 1215. 
That is, in some embodiments, the papillary muscle control 
device may be directly attached to a valve annulus, attached 
directly to an annuloplasty device, or both. The papillary 
muscle control device can be anchored using clamps, sutures, 
20 hooks, crimps, or other coupling mechanisms. If attached to 
an annuloplasty device, the papillary muscle control device 
may be permanently coupled to the annuloplasty device or 
capable of being attached and reattached to the annuloplasty 
device. Also, the annuloplasty device may be pre-implanted 
25 within a patient or implanted during the method 1200. 
After the papillary muscle control device is connected to at 
least one of a valve annulus or an annuloplasty device, the 
papillary muscle control device can then be connected to at 
least one papillary muscle at 1220. Connecting the papillary 
30 muscle control device in this manner in tum couples at least 
one papillary muscle to at least one of a valve annulus or 
annuloplasty device at 1225. Advantageously, connecting the 
papillary muscle control device in this manner can adjust or 
move a papillary muscle to rectify abnormal movement of the 
35 papillary muscle. Indeed, connecting the papillary muscle 
control device to a papillary muscle enables the position of 
the papillary muscle to be controlled and moved apically 
toward a valve annulus so that an initial apical adjustment 
occurs at 1230. The inventors have discovered that control-
10 and FIG. 11 is that the support structure 1010 in FIG. 10 
penetrates the papillary muscle 1035 and the support struc-
ture 1010 in FIG. 9 does not penetrate the papillary muscle 
1035. Rather, the support structure 1110 of device 1100 illus-
trated in FIG. 11 is positioned along the exterior of the pap-
illary muscle 1035. This configuration is beneficial and 40 
advantageous because it may be desired when penetrating a 
papillary muscle is not required. Also, this configuration may 
ling the movement of a papillary muscle in an apical direction 
can alter leaflet geometry. 
The papillary muscle control device can have various con-
be desired to assist in controlling a papillary muscle having 
reduced functionality. The support structure 1110 of device 
1100 can also be different in that it can have an interior pad 45 
1105 that curves around the tip 1030 of the papillary muscle 
1035 as shown in FIG. 11. 
nection and functional characteristics. For example, the pap-
illary muscle control device can have multiple connection 
structures. These multiple connection structures can enable 
connection or coupling between a valve annulus and to two 
papillary muscles. Also, the papillary muscle control device 
preferably comprises connection structures capable ofhaving 
adjustable lengths. For example, the connection structures 
FIG. 12 illustrates a logical flow diagram depicting a 
method 1200 embodiment of the present invention capable of 
reforming a mitral valve by controlling position of an asso-
ciated papillary muscle. According to some method embodi-
ments the complete implant or partial sections may be deliv-
ered percutaneously, and in other embodiments, the complete 
implant or partial sections may be delivered thorocoscopi-
cally in a beating heart. Those skilled in the art will under-
stand that the method 1200 is only one method embodiment 
of the present invention and that the method 1200 can have 
various steps or be performed in various orders. 
The method 1200 can initiate at 1205 during a surgical 
operation being performed on a patient. The surgical opera-
tion may be an open heart surgery to fix or repair a patient's 
heart or to correct regurgitation associated with an atrioven-
tricular valve, such as a mitral valve. In other embodiments, 
the surgical operation may be performed utilizing minimally 
invasive techniques in which surgical implants are inserted 
into a patient using lumens. The method 1200 can continue at 
1210 where a patient's heart may be stopped and bypassed by 
50 themselves can incorporate multiple parts that interact to alter 
the length of the connections structures (e.g., an interior 
threaded configuration). Alternatively, the papillary muscle 
control device can have length adjustment mechanism that 
adjust the apical distance between a papillary muscle and 
55 valve annulus by movement along the length of a support 
structure. 
The length adjustment mechanism can interact with (e.g., 
slidably engage) a support structure so that the apical distance 
can be varied to an optimal length. The optimal length may be 
60 the length that eliminates regurgitation or controls regurgita-
tion to a sufficient amount. The length adjustment mechanism 
can also have a locking mechanism (e.g., pin lock, detent 
member, or clamp) that can fix the length of the support 
structure at the optimal length. The length adjustment mecha-
65 nism can be located proximate a valve annulus, proximate a 
papillary muscle, or both according to the various embodi-
ments of the present invention. Thus, the length adjustment 
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mechanism can be utilized to adjust the length of a support 
structure so that the apical distance between a papillary 
muscle and valve annulus is modified to reduce regurgitation. 
After implantation of the papillary muscle control device, 
the surgical operation can be completed at 1235. If the surgi-
cal operation required stopping of a patient's heart, then the 
patient's heart can be restarted at this time. Preferably, the 
patient's heart will then be allowed to operate for approxi-
mately five minutes so that the function of the heart at this 
time can be close to normal operation. After waiting, further 10 
adjustments can be made to the papillary muscle control 
device at 1240. These adjustments, for example, can be made 
as a surgeon analyzes Doppler regurgitation results. Advan-
tageously, this feature enables fine tuning of the papillary 
muscle control device on a beating heart. Also this feature 15 
enables apical adjustment of a papillary muscle in real time 
while monitoring regurgitation data to control, reduce, or 
eliminate regurgitation. 
It should be understood that these further adjustments can 
be made at any time post-operation. For example, after wait- 20 
ing several minutes, a surgeon can perform the adjustments. 
Alternatively, the adjustments to the papillary muscle control 
device may occur days, months, or years after successful 
conclusion of a surgery and after a patient has healed. This 
would enable a surgeon to use minimally invasive procedures 25 
to access the papillary muscle control device to alter the 
length of a support structure thereby altering the apical dis-
tance of a papillary muscle relative to a valve annulus. Thus, 
adjustments to the papillary muscle control device can be 
repeated at 1245 as needed to control heart valve regurgitation 30 
at 1245 to complete method 1200 at 1250. 
The embodiments of the present invention are not limited 
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distance between an annulus of the heart valve and a 
papillary muscle of the heart. 
2. The system of claim 1, wherein the adjustment device is 
a remote activator and the adjustment mechanism is opera-
tively configured to receive instructions from the remote acti-
vator and in response adjust the length of the support struc-
ture. 
3. The system of claim 2, wherein the adjustment mecha-
nism is configured to transmit status information on the posi-
tion of the length of the support structure to a receiver located 
outside the body. 
4. The system of claim 1, the support structure comprising 
a first end defining an aperture configured and shaped to 
receive a corresponding end of the adjustment device, the first 
end further comprising a threaded portion capable of rotation 
relative to the support structure such that rotation of the 
adjustment device rotates the threaded portion relative to a 
corresponding portion of the support structure. 
5. The system of claim 1, the adjustment device comprising 
an elongated body configured for extension from outside the 
atrium to engage the adjustment mechanism on the first 
anchor when connected to the in situ valve. 
6. The system of claim 1, wherein the first anchor is an 
annuloplasty ring. 
7. The system of claim 6, wherein the support structure is a 
suture. 
8. The system of claim 6, wherein there are two of the 
support structures and two corresponding second anchors, 
and the support structures couple to the annuloplasty ring at 
two spaced adjustment mechanisms so as to provide adjust-
able length support structures between the two adjustment 
mechanisms and two papillary muscles within the ventricle. 
9. The system of claim 6, wherein the adjustment mecha-
nism comprises a housing secured to the annuloplasty ring 
containing an internally movable member to which the sup-
port structure fixedly attaches, the adjustment device being 
configured to displace the internally movable member with 
respect to the housing, thus displacing the support structure 
to the particular exemplary embodiments, process steps, and 
materials disclosed herein as such embodiments, process 
steps, and materials may vary somewhat. Moreover, the ter- 35 
minology employed herein is used for the purpose of describ-
ing exemplary embodiments only and the terminology is not 
intended to be limiting since the scope of the various embodi-
ments of the present invention will be limited only by the 
appended claims and equivalents thereof. 40 relative to the housing and the arnmloplasty ring to which the 
housing is secured. Thus, while the various embodiments of this invention 
have been described in detail with particular reference to 
exemplary embodiments, those skilled in the art will under-
stand that variations and modifications can be effected within 
the scope of the invention as defined in the appended claims. 
Accordingly, the scope of the various embodiments of the 
present invention should not be limited to the above discussed 
embodiments, and should only be defined by the following 
claims and all equivalents. 
We claim: 
1. A papillary muscle positioning system comprising: 
a first anchor configured to fixedly connect to an in situ 
heart valve situated in a heart between a heart ventricle 
and atrium; 
a second anchor configured to fixedly connect to at least 
one of a ventricular wall and a papillary muscle of the 
heart; 
a support structure coupled between and to the first anchor 
and the second anchor such that adjusting a length of the 
support structure varies a distance between the first 
anchor and the second anchor; 
an adjustment mechanism at the first anchor configured to 
lockably adjust the length of the support structure; and 
10. The system of claim 9, wherein the internally movable 
member is a threaded nut engaged to a threaded bolt having a 
head, the adjustment device comprising an elongated body 
45 configured for extension from outside the atrium to engage 
and rotate the head of the threaded bolt and displace the 
threaded nut within the housing. 
11. The system of claim 10, wherein the support structure 
is a suture and the threaded nut includes an attachment point 
50 to which the suture is secured. 
12. The system of claim 1, wherein the support structure 
has a unidirectional bending structure. 
13. The system of claim 12, wherein there are two of the 
support structures and two corresponding second anchors, 
55 and the support structures couple to two spaced first anchors 
so as to provide adjustable length support structures between 
the two first anchors and two papillary muscles within the 
ventricle, and wherein the unidirectional bending structure in 
each of the support structures cause the support structures to 
60 flex inward toward each other when subjected to compressive 
stresses. 
14. The system of claim 1, wherein the first anchor is an 
annulus anchor having flexible arms that extend at least par-
tially around a perimeter of the arnmlus. 
an adjustment device for adjusting, from outside the heart 65 
and while the heart is beating, the adjustment mecha-
nism to adjust the length of the support structure and a 
15. The system of claim 1, the second anchor comprising a 
pad, wherein the support structure is coupled to the pad for 
attachment to the papillary muscle. 
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16. The system of claim 1, wherein the support structure 
comprises an elongated rod. 
17. The system of claim 1, wherein the support structure 
comprises a wire. 
26 
respect to the housing, thus displacing the support structure 
relative to the housing and the annuloplasty ring to which the 
housing is secured. 
26. The system of claim 25, adjustment mechanism is 
operatively configured to receive instructions from a remote 
activator and in response adjust the length of the support 
structure. 
18. The system of claim 1, wherein the support structure 
comprises a pair of relatively movable elongated members at 
least one of which having an interior for receiving an end of 
the other elongated member, the two elongated members 
having cooperating threads for adjusting their axial positions 
with respect to one another. 
27. The system of claim 26, wherein the adjustment mecha-
nism is configured to transmit status information on the posi-
10 ti on of the length of the support structure to a receiver located 
.19. !he systei:i ?f claim 18, further including a security 
Wife disposed w1thm and through the interior of the support 
structure. 
20. A papillary muscle positioning system comprising: 
an ammloplasty ring configured to fixedly connect to an in 15 
situ heart valve situated in a heart between a heart ven-
tricle and atrium; 
an anchor configured to fixedly connect to at least one of a 
ventricular wall and a papillary muscle of the heart; 
a support structure coupled between and to the annulo- 20 
plasty ring and the anchor such that adjusting a length of 
the support structure varies a distance between the annu-
loplasty ring and the anchor; 
an adjustment mechanism at the annuloplasty ring for lock-
ably adjusting the length of the support structure while 25 
the heart is beating such that a distance between an 
annulus of the heart valve and a papillary muscle is 
adjusted. 
21. The system of claim 20, the support structure compris-
ing a first end defining an aperture, the first end further com- 30 
prising a threaded portion capable of rotation relative to the 
support structure to adjust the length thereof. 
22. The system of claim 21, the adjustment device com-
prising an elongated body configured for extension from out-
side the atrium to engage the aperture on the first end of the 35 
support structure. 
. 23. The system of claim 20, wherein the support structure 
1s a suture. 
24. The system of claim 20, wherein there are two of the 
support structures and two corresponding anchors, and the 40 
support structures couple to the annuloplasty ring at two 
spaced adjustment mechanisms so as to provide adjustable 
length support structures between the two adjustment mecha-
nisms and two papillary muscles within the ventricle. 
25. The system of claim20, wherein the adjustmentmecha- 45 
nism .c~mpris~s a housing secured to the annuloplasty ring 
contmmng an mtemally movable member to which the sup-
port structure fixedly attaches, the adjustment device being 
configured to displace the internally movable member with 
outside the body. 
28. The system of claim 25, wherein the internally movable 
member is a threaded nut engaged to a threaded bolt having a 
head, the adjustment device comprising an elongated body 
configured for extension from outside the atrium to engage 
and rotate the head of the threaded bolt and displace the 
threaded nut within the housing. 
29. The system of claim 28, wherein the support structure 
is a suture and the threaded nut includes an attachment point 
to which the suture is secured. 
30. The system of claim 20, wherein the support structure 
has a unidirectional bending structure. 
31. The system of claim 30, wherein there are two of the 
support structures and two corresponding anchors, and the 
support structures couple to two spaced locations on the annu-
loplasty ring so as to provide adjustable length support struc-
~res between the ~o spaced locations on the annuloplasty 
nng and two papillary muscles within the ventricle and 
wherein the unidirectional bending structure in each ~f the 
support structures cause the support structures to flex inward 
toward each other when subjected to compressive stresses. 
32. !he system of claim 20, the anchor comprising a pad, 
wherem the support structure is coupled to the pad for attach-
ment to the papillary muscle. 
33. The system of claim 20, wherein the support structure 
comprises an elongated rod. 
34. The system of claim 20, wherein the support structure 
comprises a wire. 
35. The system of claim 20, wherein the support structure 
comprises a pair of relatively movable elongated members at 
least one of which having an interior for receiving an end of 
the other elongated member, the two elongated members 
having cooperating threads or adjusting their axial positions 
with respect to one another. 
36. The system of claim 35, further including a security 
wire disposed within and through the interior of the support 
structure. 
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